Rare Disease Day: Lighting the Path for the Canavan Community
Article Date
May 3, 2026
This article is featured on another website.
Go to article
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
September 23, 2026
Chime Biologics and Magic Mirror Biotech Enter Strategic Partnership to Advance AI-Enabled Intelligent Manufacturing Across the Biologics Lifecycle
September 23, 2026